Reference health
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection
65/65 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 65 checked references that resolve
resolves10.1128/CMR.6.3.230
Leishmaniases of the New World: current concepts and implications for future research
resolves10.1517/17425247.2010.529897
New delivery strategies for the old pentavalent antimonial drugs
resolves10.3389/fimmu.2014.00380
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
resolves10.1186/s13071-016-1553-y
Possibilities and challenges for developing a successful vaccine for leishmaniasis
resolves10.4049/jimmunol.169.11.6580
Increased Nonobese Diabetic Th1:Th2 (IFN-γ:IL-4) Ratio Is CD4+ T Cell Intrinsic and Independent of APC Genetic Background
resolves10.1016/j.micinf.2017.03.002
Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects
resolves10.1016/j.imbio.2017.10.043
Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis
resolves10.1371/journal.pntd.0004468
Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production
resolves10.3389/fcimb.2017.00200
IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis
resolves10.1371/journal.pntd.0003198
Leishmania Specific CD4 T Cells Release IFNγ That Limits Parasite Replication in Patients with Visceral Leishmaniasis
resolves10.3389/fimmu.2018.00843
Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters
resolves10.1111/sji.12557
A Non‐pathogenic Recombinant <i>Leishmania</i> Expressing Lipophosphoglycan 3 Against Experimental Infection with <i>Leishmania infantum</i>
resolves10.4049/jimmunol.1700674
Live Attenuated <i>Leishmania donovani</i> Centrin Gene–Deleted Parasites Induce IL-23–Dependent IL-17–Protective Immune Response against Visceral Leishmaniasis in a Murine Model
resolves10.1371/journal.pntd.0004322
Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters
resolves10.1016/j.vaccine.2018.03.027
Immunotherapeutic potential of Leishmania ( Leishmania ) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis
resolves10.1111/pim.12287
Prophylactic properties of a <i>Leishmania</i>‐specific hypothetical protein in a murine model of visceral leishmaniasis
resolves10.1016/j.molimm.2018.12.025
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection
resolves10.4103/ijpvm.IJPVM_116_18
Leishmania Vaccines Entered in Clinical Trials: A Review of Literature
resolves10.1016/j.vaccine.2019.04.092
Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
resolves10.1016/j.molimm.2016.06.014
A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection
resolves10.3389/fcimb.2018.00112
Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis
resolves10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f
Correction: Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral Leishmaniasis
resolves10.1016/j.diagmicrobio.2018.05.026
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up
resolves10.1016/j.bbrc.2003.10.148
A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis
resolves10.1093/emboj/19.11.2444
Prohibitins act as a membrane‐bound chaperone for the stabilization of mitochondrial proteins
resolves10.1111/j.1462-5822.2009.01406.x
<i>Leishmania</i>cell surface prohibitin: role in host-parasite interaction
resolves10.1016/j.cellimm.2017.11.001
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis
resolves10.1159/000109115
Biochemistry and Function of Hypusine Formation on Eukaryotic Initiation Factor 5A
resolves10.1128/CVI.00465-15
Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis
resolves10.1017/S0031182019000714
Screening diagnostic candidates from<i>Leishmania infantum</i>proteins for human visceral leishmaniasis using an immunoproteomics approach
resolves10.1016/j.trsl.2018.05.001
Vaccination with a CD4+ and CD8+ T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis
resolves10.1016/j.micpath.2019.103704
Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach
resolves10.3389/fimmu.2019.00288
Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani
resolves10.1016/j.cellimm.2016.12.008
A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection
resolves10.3389/fcimb.2018.00381
Cellular Markers of Active Disease and Cure in Different Forms of Leishmania infantum-Induced Disease
resolves10.1016/j.actatropica.2015.11.006
A new Leishmania-specific hypothetical protein, LiHyT, used as a vaccine antigen against visceral leishmaniasis
resolves10.1016/j.molimm.2017.09.017
Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis
resolves10.1016/j.cyto.2018.08.019
A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis
resolves10.1111/pim.12359
A recombinant chimeric protein composed of human and mice‐specific <scp>CD</scp>4<sup>+</sup> and <scp>CD</scp>8<sup>+</sup> T‐cell epitopes protects against visceral leishmaniasis
resolves10.1016/j.pt.2015.08.001
Induction, Propagation, and Activity of Host Nitric Oxide: Lessons from Leishmania Infection
resolves10.1128/IAI.71.11.6499-6509.2003
Recombinant<i>Leishmania major</i>Secreting Biologically Active Granulocyte-Macrophage Colony-Stimulating Factor Survives Poorly in Macrophages In Vitro and Delays Disease Development in Mice
resolves10.1172/JCI117767
Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
resolves10.1016/j.micinf.2010.06.008
Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge
resolves10.1016/S0264-410X(01)00469-8
Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor
resolves10.1038/s41598-017-08842-w
Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach
resolves10.1080/07391102.2018.1484815
Exploratory algorithm to devise multi-epitope subunit vaccine by investigating <i>Leishmania donovani</i> membrane proteins
resolves10.3389/fimmu.2014.00241
Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
resolves10.1186/s13071-017-2576-8
Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection
resolves10.3390/ijms20081812
Leishmania infantum β-Tubulin Identified by Reverse Engineering Technology through Phage Display Applied as Theranostic Marker for Human Visceral Leishmaniasis
resolves10.1016/j.cyto.2020.155031
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis
resolves10.1111/imm.12889
Improved methods for predicting peptide binding affinity to <scp>MHC</scp> class <scp>II</scp> molecules
resolves10.1073/pnas.0709717105
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7
resolves10.1016/0014-5793(90)80535-Q
A semi‐empirical method for prediction of antigenic determinants on protein antigens
resolves10.1093/nar/gkx346
BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes
resolves10.1080/22221751.2019.1635430
A rapid diagnostic test for human Visceral Leishmaniasis using novel
<i>Leishmania</i>
antigens in a Laser Direct-Write Lateral Flow Device
resolves10.1016/0003-2697(76)90527-3
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
resolves10.1016/0003-2697(82)90118-X
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
The 6 references without a DOI — listed, not checked
no DOI — not checkedSundar, S. & Singh, A. Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther. Adv. Infect. Dis. 3, 98–109 (2016).
no DOI — not checkedMishra, J., Dey, A., Singh, N., Somvanshi, R. & Singh, S. Evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin B in a mouse model. Indian J. Med. Res. 137, 767–776 (2013).
no DOI — not checkedCoelho, V. T. et al. Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Negl. Trop. Dis. 6, e1430 (2012).
no DOI — not checkedJaiswal, A. K. et al. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis. PLoS ONE 9, e108556 (2014).
no DOI — not checkedJoshi, S. et al. Comparative analysis of cellular immune responses in treated Leishmania Patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani. Front. Microbiol. 7, 312 (2016).
no DOI — not checkedBadaro, R. et al. Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report. Braz. J. Infect. Dis. 5, 223–232 (2001).
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1038/s41541-020-00224-0"><img src="https://citestamp.com/citestamped/10.1038/s41541-020-00224-0/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1038/s41541-020-00224-0)